Indication
Lazertinib
1 clinical trial
1 product
1 drug
Clinical trial
A Randomized Phase II Study of LAZE Rti N ib Alone Versus Lazertinib Plus Beva C Izumab for A Dvanced Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations and Smoking HistoryStatus: Recruiting, Estimated PCD: 2026-09-05
Drug
LazertinibProduct
Bevacizumab